论文部分内容阅读
氟他胺是非甾体类雄激素拮抗剂,用于治疗前列腺癌100例,采用美国生产缓退瘤(Fugerel)治疗前列腺癌31例作为对照组。结果氟他胺组有效率86％,缓退瘤组有效率87.09％,两组无显著差异,均无明显不良反应,结果表明氟他胺是一种治疗前列腺癌较满意药物。
Flutamide is a non-steroidal androgen antagonist that is used to treat 100 cases of prostate cancer. 31 cases of prostate cancer were treated with Fugerel in the United States as a control group. Results The effective rate was 86% in the flutamide group and 87.09% in the slow-tumor group. There was no significant difference between the two groups. There was no obvious adverse reaction. The results showed that flutamide was a more satisfactory drug for the treatment of prostate cancer.